KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Other Non-Current Liabilities (2016 - 2025)

Thermo Fisher Scientific's Other Non-Current Liabilities history spans 17 years, with the latest figure at $4.3 billion for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities rose 7.12% year-over-year to $4.3 billion, compared with a TTM value of $4.3 billion through Dec 2025, up 7.12%, and an annual FY2025 reading of $4.3 billion, up 7.12% over the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $4.3 billion at Thermo Fisher Scientific, roughly flat from $4.3 billion in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $4.7 billion in Q2 2022, with the low at $3.4 billion in Q2 2021.
  • Average Other Non-Current Liabilities over 5 years is $4.2 billion, with a median of $4.3 billion recorded in 2025.
  • Year-over-year, Other Non-Current Liabilities skyrocketed 39.14% in 2022 and then decreased 14.07% in 2024.
  • Tracing TMO's Other Non-Current Liabilities over 5 years: stood at $4.5 billion in 2021, then decreased by 6.65% to $4.2 billion in 2022, then increased by 9.53% to $4.6 billion in 2023, then dropped by 14.07% to $4.0 billion in 2024, then grew by 7.12% to $4.3 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Other Non-Current Liabilities are $4.3 billion (Q4 2025), $4.3 billion (Q3 2025), and $4.3 billion (Q2 2025).